Infl Combination Liquid
NDC Package 43742-2174-1
Package Information
Infl Combination (aconitum napellus, adenoviren nosode, bryonia (alba), eucalyptus globulus, eupatorium perfoliatum, gelsemium sempervirens, influenzinum 2023-2024, ipecacuanha, kreosotum, veratrum viride) liquids is 1-10 drops under the tongue, 3 times a day or as directed by a health professional. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-2174.
Identification & Billing
Clinical Specifications
- ACONITUM NAPELLUS WHOLE 6 [hp_C]/mL
- BRYONIA ALBA ROOT 30 [hp_C]/mL
- EUCALYPTUS GLOBULUS LEAF 2 [hp_C]/mL
- EUPATORIUM PERFOLIATUM FLOWERING TOP 30 [hp_C]/mL
- GELSEMIUM SEMPERVIRENS ROOT 30 [hp_C]/mL
- HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 9 [hp_C]/mL
- INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE 10 [hp_C]/mL
- INFLUENZA A VIRUS WHOLE 10 [hp_C]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 10 [hp_C]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 10 [hp_X]/mL
- IPECAC 3 [hp_C]/mL
- VERATRUM VIRIDE ROOT 30 [hp_C]/mL
- WOOD CREOSOTE 30 [hp_C]/mL
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc.
- 43742-2174 - Infl Combination
- 43742-2174-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-2174 - Infl Combination
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-2174-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Infl Combination, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains aconitum napellus whole; bryonia alba root; eucalyptus globulus leaf; eupatorium perfoliatum flowering top; gelsemium sempervirens root; human adenovirus e serotype 4 strain cl-68578 antigen; influenza a virus a/darwin/6/2021 (h3n2) whole; influenza a virus whole; influenza b virus b/austria/1359417/2021 bvr-26 whole; influenza b virus b/phuket/3073/2013 bvr-1b whole; ipecac; veratrum viride root; wood creosote as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on May 14, 2024.
How is this Deseret Biologicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742217401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.